BTAI
BioXcel Therapeutics Inc
NASDAQ: BTAI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
-1.89% today
Updated 2026-04-29
Market cap
$28.70M
P/E ratio
—
P/S ratio
44.70x
EPS (TTM)
$-5.73
Dividend yield
—
52W range
$1 – $8
Volume
1.8M
BioXcel Therapeutics Inc (BTAI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |